<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-688-CA-A-00-08-00062-1</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Maternal and Child Health - Treatment of Child Illness</narrative>
   <narrative xml:lang="FR">Maternel et sant&#xE9;s de l&apos;enfant - traitement de maladie d&apos;enfant</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">Maternal and Child Health - Increase boys and girls access to and utilization of appropriate treatment for diarrhea, pneumonia, and other potentially life-threatening childhood illnesses, including improved recognition of serious illness, community and facility-based treatment of uncomplicated pneumonia, recognition and treatment of severe and complicated pneumonia, Oral Rehydration Therapy, introduction of new formulation ORS, introduction and evaluation of zinc treatment, antibiotic treatment of dysentery, and management of persistent diarrhea. (Malaria detection in children should be budgeted here, but treatment and prevention in the malaria element.)</narrative>
   <narrative xml:lang="FR">Maternel et sant&#xE9;s de l&apos;enfant - acc&#xE8;s de gar&#xE7;ons et de filles d&apos;augmentation &#xE0; et utilisation de traitement appropri&#xE9; pour la diarrh&#xE9;e, la pneumonie, et d&apos;autres maladies infantiles potentiellement potentiellement mortelles, y compris la reconnaissance am&#xE9;lior&#xE9;e de la maladie grave, la communaut&#xE9; et le traitement bas&#xE9; sur installation de la pneumonie peu compliqu&#xE9;e, la reconnaissance et le traitement de la pneumonie grave et compliqu&#xE9;e, la th&#xE9;rapie orale de r&#xE9;hydration, l&apos;introduction de la nouvelle formulation ORS, l&apos;introduction et l&apos;&#xE9;valuation du traitement de zinc, du traitement antibiotique de la dysenterie, et de la gestion de la diarrh&#xE9;e persistante. (La d&#xE9;tection de malaria chez les enfants devrait &#xEA;tre &#xE9;conomis&#xE9;e ici, mais traitement et pr&#xE9;vention dans l&apos;&#xE9;l&#xE9;ment de malaria.)</narrative>
  </description>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="XI-DUNS-037799178" role="4" type="22">
   <narrative xml:lang="EN">Helen Keller International</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2015-10-01" type="1"></activity-date>
  <activity-date iso-date="2015-10-01" type="2"></activity-date>
  <activity-date iso-date="2016-09-30" type="3"></activity-date>
  <activity-date iso-date="2016-09-30" type="4"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN">Dana Alzouma</narrative>
   </person-name>
   <telephone>+1 202-712-0432</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/mali</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction ref="8FE61AFF94B5">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-09-30"></transaction-date>
   <value currency="USD" value-date="2016-09-30">-52234.11</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="12220" vocabulary="1">
    <narrative xml:lang="EN">Basic health care</narrative>
   </sector>
   <sector code="3006" vocabulary="99">
    <narrative xml:lang="EN">Maternal and Child Health</narrative>
   </sector>
   <recipient-country code="ML"></recipient-country>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2010" end="2011"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:duns-number>
   <narrative>37799178</narrative>
  </usg:duns-number>
  <usg:mechanism-signing-date iso-date="2021-10-01"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Mali</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>956826.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
